Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. We believe that a healthy economy, environment and society are fundamental to long-term value creation. This is why we manage our business in accordance with the Triple Bottom Line business principle and consider the financial, environmental and social impact of our business decisions. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today's business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance.
POSTED
11-30-11
As of 28 November 2011, Novo Nordisk will no longer use living animals to test the quality of the batches of medicine coming out of Novo Nordisk’s production lines. These tests have for years been required by health authorities as part of their approval of the products.
“Today’s achievemen...
POSTED
11-24-11
On 18 November 2011, a supplement made possible through an unrestricted educational grant by Novo Nordisk was published by the International Journal of Gynecology and Obstetrics. The supplement, “From biology to policy: The link between maternal health and current and future burden of chronic non...
POSTED
10-31-11
In October 2011, the Health Secretary of Barranqilla with support from Novo Nordisk launched the "Vida Nueva" (New Life) Project for Gestational Diabetes in Barranquilla, Colombia. Vida Nueva, a key activity in Novo Nordisk's Changing Diabetes® in Pregnancy programme, seeks to diagnose and treat ...
POSTED
09-09-11
With more than 50 million people living with diabetes in India and only scarce data existing about children with diabetes, Novo Nordisk today launched the Changing Diabetes® in Children (CDiC) programme in the country. The programme is a partnership initiative that works to improve the...
POSTED
06-07-11
Novo Nordisk's own film production department, FilmSolutions, won two awards at the World Media Festival in Hamburg for a documentary about Novo Nordisk's Changing Diabetes® in Children project in Bangladesh.
The film was produced last year duri...
POSTED
05-25-11
In recognition of their rapid response to last year's devastating floods in Pakistan, employees from Novo Nordisk Pakistan were voted the 2010 TakeAction award winners. The award, given to the most impressive employee volunteer activity of the year, was announced at Novo Nor...
POSTED
03-30-11
In its second Blueprint for Change Programme business case, Novo Nordisk reports that its Triple Bottom Line business principle, balancing economic, social and environmental decisions, has created value for both the Chinese society and Novo Nordisk.
POSTED
02-14-11
Novo Nordisk reports strong financial, social and environmental performance for 2010 Novo Nordisk, the world leader in diabetes care, has released its seventh annual integrated report with 2010 results. The company’s achievements for the year include solid sales growth, prog...
POSTED
01-28-11
Underscoring the role of business in addressing global threats - from climate change to widespread poverty or humanitarian emergencies - a group of chief executives joined UN Secretary-General Ban Ki-moon in Davos/Switzerland today for the launch of Global Compact LEAD - a n...
POSTED
01-27-11
At the World Economic Forum, currently taking place in Davos, a group of leading CEO’s have introduced the so-called Workplace Wellness Alliance. This consortium of corporations including Novo Nordisk, Nestlé, Johnson & Johnson, Unilever, BT and others, have partnered up...